Ok. TIme for some weekend pumping rehashed hopium.
After a successful career, Dr. Leidtke decides to join our company after our flagship drug got a chmp rejection. Interesting move to say the least. Missling resurrects the idea of starting multiple trials as the FDA pivots to one pivotal trial and embraces a Bayesian framework. Prescient, lucky or inside information. Nell gets promoted while working with lobbyists in DC. What perfect timing to start a multitude of trials that have been on pause with Leidtke, Kun Jin and Sabbagh leading the charge.
Missling starts talking more collaborations and possible partnerships and heads to JPM to entice investors.
After their practice run with CHMP, Missling sends over an NDA style complete package with all the fixins. Makary starts drooling and says, oh damn, you can safely treat over half of Alzheimer's patients orally with precision medicine? Voucher coming in a press conference as Trump touts a major CNS win in time for the mid-terms?
Partners negotiating, Leidtke Designing and planning, Promoted Nell Schmoozing, informed SAG reviewing, Makary drooling, Access-Ad moving and shareholders winning with SP increase following.
Pretty good set up! All happening at the same time.
Market Data 
Markets 
